Professional opportunity for pharmacists to integrate pharmacogenomics in medication therapy

Abstract

Get full access to this article

View all access options for this article.

References

Ritchie

. The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Hum Genet 2012;131(10):1615–26.

Crews

Hicks

Pui

et al . Pharmacogenomics and individualized medicine: translating science into practice. Clin Pharmacol Ther 2012;92(4):467–75.

Zanger

Schwab

. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Clin Pharmacol Ther 2013;138(1):103–41.

Table of pharmacogenomics biomarkers in drug labeling—FDA. Available: www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm (accessed Mar. 1, 2018).

Clinical pharmacology section of labeling for human prescription drug and biological products—content and format guidance for industry. Available: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM109739.pdf (accessed Mar. 1, 2018).

Notice—revision to guidance document: submission of pharmacogenomic information. Available: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-pharmacogenomic-information.html (accessed Mar. 1, 2018).

Lewis

Traylor

Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe. BMC Med Genomics 2017;10(1):47.

Phillips

AM.

Only a click away—DTC genetics for ancestry, health, love . . . and more: a view of the business and regulatory landscape. Appl Transl Genom 2016;8:16-22.

Mills

Haga

SB.

Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists. Pharmacogenomics 2013;14(8):957–68.

10.

Roederer

Kuo

Kisor

et al . Pharmacogenomics competencies in pharmacy practice: a blueprint for change. J Am Pharm Assoc 2017;57(1):120–5.

11.

Relling

Klein

. CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther 2011;89(3):464–7.

12.

PharmGKB Dosing guidelines. Available: https://www.pharmgkb.org/guidelines (accessed Mar. 1, 2018).

13.

Johnson

JA.

Pharmacogenetics in clinical practice: how far have we come and where are we going?

Pharmacogenomics 2013;14(7):835–43.

14.

Sorich

Rowland

Wiese

. Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes. Ther Adv Drug Saf 2014;5(2):62–6.

15.

CAMH IMPACT study. Available: http://impact.camhx.ca/en/home.php (accessed Mar. 1, 2018).

16.

Pharmacogenomics Centre. Available: http://www.pharmacogenomics.ca/ (accessed Mar. 1, 2018).

17.

Kim

. Personalized medicine. Available: https://www.schulich.uwo.ca/clinpharm/education/clinical_programs/personalized_medicine.html (accessed Mar. 1, 2018).

18.

Pharmacogenomics Canada. Available: https://rxome.ca/ (accessed Mar. 1, 2018).